The BTBD9 gene may be associated with antipsychotic-induced restless legs syndrome in schizophrenia

Seung Gul Kang, Heon-Jeong Lee, Young Min Park, Hee Jung Yang, Hyun Mi Song, Yu Jin Lee, Seong Jin Cho, Sung Nam Cho, Leen Kim

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objective A genome-wide association study and several replication studies have shown significant association between BTBD9 gene single nucleotide polymorphisms and restless legs syndrome (RLS). The aim of this study is to investigate the association between the BTBD9 gene polymorphisms and antipsychotic-induced RLS in schizophrenic patients. Methods Restless legs syndrome symptoms were evaluated using the diagnostic criteria of the International Restless Legs Syndrome Study Group in 190 Korean schizophrenic patients. We genotyped the rs9357271 and rs3923809 polymorphisms of the BTBD9 gene in schizophrenic patients with (n = 96) and without (n = 94) RLS symptoms. Results There was a significant difference in the allele frequency (χ2 = 8.14, p = 0.004) of the rs9357271 polymorphism between schizophrenic patients with and without RLS symptoms. Significant genotypic association of this single nucleotide polymorphisms with RLS symptoms was also observed for the dominant model (χ2 = 10.32, p = 0.001) and heterozygous model (χ2 = 10.9, p = 0.001). When we compared the frequencies of the rs3923809-rs9357271 haplotypes between the two groups, the overall haplotype frequencies were significantly different (permuted p = 0.037), and the A-T haplotype was significantly more frequent in the RLS symptom group than in the no RLS symptom group (0.112 vs. 0.041, permuted p = 0.007). Conclusions These data suggest that the BTBD9 gene is associated with antipsychotic-induced RLS symptoms in schizophrenic patients.

Original languageEnglish
Pages (from-to)117-123
Number of pages7
JournalHuman Psychopharmacology
Volume28
Issue number2
DOIs
Publication statusPublished - 2013 Mar 1

Fingerprint

Restless Legs Syndrome
Antipsychotic Agents
Schizophrenia
Genes
Haplotypes
Single Nucleotide Polymorphism
Genome-Wide Association Study
Gene Frequency

Keywords

  • antipsychotics
  • BTBD9 gene
  • polymorphism
  • restless legs syndrome
  • schizophrenia

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Neurology
  • Pharmacology (medical)

Cite this

The BTBD9 gene may be associated with antipsychotic-induced restless legs syndrome in schizophrenia. / Kang, Seung Gul; Lee, Heon-Jeong; Park, Young Min; Yang, Hee Jung; Song, Hyun Mi; Lee, Yu Jin; Cho, Seong Jin; Cho, Sung Nam; Kim, Leen.

In: Human Psychopharmacology, Vol. 28, No. 2, 01.03.2013, p. 117-123.

Research output: Contribution to journalArticle

Kang, Seung Gul ; Lee, Heon-Jeong ; Park, Young Min ; Yang, Hee Jung ; Song, Hyun Mi ; Lee, Yu Jin ; Cho, Seong Jin ; Cho, Sung Nam ; Kim, Leen. / The BTBD9 gene may be associated with antipsychotic-induced restless legs syndrome in schizophrenia. In: Human Psychopharmacology. 2013 ; Vol. 28, No. 2. pp. 117-123.
@article{d7de22e6f6d547d8b4ae01437fc03074,
title = "The BTBD9 gene may be associated with antipsychotic-induced restless legs syndrome in schizophrenia",
abstract = "Objective A genome-wide association study and several replication studies have shown significant association between BTBD9 gene single nucleotide polymorphisms and restless legs syndrome (RLS). The aim of this study is to investigate the association between the BTBD9 gene polymorphisms and antipsychotic-induced RLS in schizophrenic patients. Methods Restless legs syndrome symptoms were evaluated using the diagnostic criteria of the International Restless Legs Syndrome Study Group in 190 Korean schizophrenic patients. We genotyped the rs9357271 and rs3923809 polymorphisms of the BTBD9 gene in schizophrenic patients with (n = 96) and without (n = 94) RLS symptoms. Results There was a significant difference in the allele frequency (χ2 = 8.14, p = 0.004) of the rs9357271 polymorphism between schizophrenic patients with and without RLS symptoms. Significant genotypic association of this single nucleotide polymorphisms with RLS symptoms was also observed for the dominant model (χ2 = 10.32, p = 0.001) and heterozygous model (χ2 = 10.9, p = 0.001). When we compared the frequencies of the rs3923809-rs9357271 haplotypes between the two groups, the overall haplotype frequencies were significantly different (permuted p = 0.037), and the A-T haplotype was significantly more frequent in the RLS symptom group than in the no RLS symptom group (0.112 vs. 0.041, permuted p = 0.007). Conclusions These data suggest that the BTBD9 gene is associated with antipsychotic-induced RLS symptoms in schizophrenic patients.",
keywords = "antipsychotics, BTBD9 gene, polymorphism, restless legs syndrome, schizophrenia",
author = "Kang, {Seung Gul} and Heon-Jeong Lee and Park, {Young Min} and Yang, {Hee Jung} and Song, {Hyun Mi} and Lee, {Yu Jin} and Cho, {Seong Jin} and Cho, {Sung Nam} and Leen Kim",
year = "2013",
month = "3",
day = "1",
doi = "10.1002/hup.2287",
language = "English",
volume = "28",
pages = "117--123",
journal = "Human Psychopharmacology",
issn = "0885-6222",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

TY - JOUR

T1 - The BTBD9 gene may be associated with antipsychotic-induced restless legs syndrome in schizophrenia

AU - Kang, Seung Gul

AU - Lee, Heon-Jeong

AU - Park, Young Min

AU - Yang, Hee Jung

AU - Song, Hyun Mi

AU - Lee, Yu Jin

AU - Cho, Seong Jin

AU - Cho, Sung Nam

AU - Kim, Leen

PY - 2013/3/1

Y1 - 2013/3/1

N2 - Objective A genome-wide association study and several replication studies have shown significant association between BTBD9 gene single nucleotide polymorphisms and restless legs syndrome (RLS). The aim of this study is to investigate the association between the BTBD9 gene polymorphisms and antipsychotic-induced RLS in schizophrenic patients. Methods Restless legs syndrome symptoms were evaluated using the diagnostic criteria of the International Restless Legs Syndrome Study Group in 190 Korean schizophrenic patients. We genotyped the rs9357271 and rs3923809 polymorphisms of the BTBD9 gene in schizophrenic patients with (n = 96) and without (n = 94) RLS symptoms. Results There was a significant difference in the allele frequency (χ2 = 8.14, p = 0.004) of the rs9357271 polymorphism between schizophrenic patients with and without RLS symptoms. Significant genotypic association of this single nucleotide polymorphisms with RLS symptoms was also observed for the dominant model (χ2 = 10.32, p = 0.001) and heterozygous model (χ2 = 10.9, p = 0.001). When we compared the frequencies of the rs3923809-rs9357271 haplotypes between the two groups, the overall haplotype frequencies were significantly different (permuted p = 0.037), and the A-T haplotype was significantly more frequent in the RLS symptom group than in the no RLS symptom group (0.112 vs. 0.041, permuted p = 0.007). Conclusions These data suggest that the BTBD9 gene is associated with antipsychotic-induced RLS symptoms in schizophrenic patients.

AB - Objective A genome-wide association study and several replication studies have shown significant association between BTBD9 gene single nucleotide polymorphisms and restless legs syndrome (RLS). The aim of this study is to investigate the association between the BTBD9 gene polymorphisms and antipsychotic-induced RLS in schizophrenic patients. Methods Restless legs syndrome symptoms were evaluated using the diagnostic criteria of the International Restless Legs Syndrome Study Group in 190 Korean schizophrenic patients. We genotyped the rs9357271 and rs3923809 polymorphisms of the BTBD9 gene in schizophrenic patients with (n = 96) and without (n = 94) RLS symptoms. Results There was a significant difference in the allele frequency (χ2 = 8.14, p = 0.004) of the rs9357271 polymorphism between schizophrenic patients with and without RLS symptoms. Significant genotypic association of this single nucleotide polymorphisms with RLS symptoms was also observed for the dominant model (χ2 = 10.32, p = 0.001) and heterozygous model (χ2 = 10.9, p = 0.001). When we compared the frequencies of the rs3923809-rs9357271 haplotypes between the two groups, the overall haplotype frequencies were significantly different (permuted p = 0.037), and the A-T haplotype was significantly more frequent in the RLS symptom group than in the no RLS symptom group (0.112 vs. 0.041, permuted p = 0.007). Conclusions These data suggest that the BTBD9 gene is associated with antipsychotic-induced RLS symptoms in schizophrenic patients.

KW - antipsychotics

KW - BTBD9 gene

KW - polymorphism

KW - restless legs syndrome

KW - schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=84875663966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875663966&partnerID=8YFLogxK

U2 - 10.1002/hup.2287

DO - 10.1002/hup.2287

M3 - Article

VL - 28

SP - 117

EP - 123

JO - Human Psychopharmacology

JF - Human Psychopharmacology

SN - 0885-6222

IS - 2

ER -